Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation

Stem Cells

Volumn 33, Issue 8, 2015, Pages 2613-2627

  Salabei, Joshua K ^a   Lorkiewicz, Pawel K ^a   Holden, Candice R ^a   Li, Qianhong ^a   Hong, Kyung U ^a   Bolli, Roberto ^a   Bhatnagar, Aruni ^a,b   Hill, Bradford G ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bioenergetics; Cell therapy; Heart failure; Mitochondria; Proliferation; Stem cells

Indexed keywords

2 OXOGLUTARIC ACID; ALPHA SMOOTH MUSCLE ACTIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLUTAMINE; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; NUCLEOTIDE; PALMITIC ACID; PHOSPHOLIPID; PROTEIN KINASE B; PYRUVIC ACID; RETINOBLASTOMA PROTEIN; STEM CELL ANTIGEN 1; TROPONIN T; VASCULOTROPIN RECEPTOR 2; MUSCLE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; BIOSYNTHESIS; CARDIAC STEM CELL; CELL ACTIVITY; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL METABOLISM; CELL PROLIFERATION; CELL RESPIRATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE; CYTOLOGY; GENE EXPRESSION REGULATION; GLYCOLYSIS; METABOLISM; PHYSIOLOGY; STEM CELL;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GLUTAMINE; GLYCOLYSIS; MICE; MUSCLE PROTEINS; MYOCARDIUM; STEM CELLS;

EID: 84937637388     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2047     Document Type: Article

References (73)

1. Smith AJ, Lewis FC, Aquila I, et al., Isolation and characterization of resident endogenous c-Kit(+) cardiac stem cells from the adult mouse and rat heart. Nat Prot 2014; 9: 1662-1681.
2. Toko H, Hariharan N, Konstandin MH, et al., Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells. J Biol Chem 2014; 289: 5348-5356.
3. Matuszczak S, Czapla J, Jarosz-Biej M, et al., Characteristic of c-Kit progenitor cells in explanted human hearts. Clin Res Cardiol 2014; 103: 711-718.
4. Beltrami AP, Barlucchi L, Torella D, et al., Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
5. Ellison GM, Vicinanza C, Smith AJ, et al., Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013; 154: 827-842.
6. van Berlo JH, Kanisicak O, Maillet M, et al., c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 2014; 509: 337-341.
7. Fischer KM, Cottage CT, Wu W, et al., Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009; 120: 2077-2087.
8. Hong KU, Guo Y, Li QH, et al., c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart. PLoS One 2014; 9: e96725.
9. Zhang LX, DeNicola M, Qin X, et al., Specific Inhibition of HDAC4 in Cardiac Progenitor Cells Enhances Myocardial Repairs. Am J Physiol Cell Physiol 2014; 307: C358-C372.
10. Zakharova L, Nural-Guvener H, Feehery L, et al., Retrograde coronary vein infusion of cardiac explant-derived c-Kit+ cells improves function in ischemic heart failure. J Heart Lung Transplant 2014; 33: 644-653.
11. Bolli R, Tang XL, Sanganalmath SK, et al., Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013; 128: 122-131.
12. Loffredo FS, Steinhauser ML, Gannon J, et al., Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011; 8: 389-398.
13. Dawn B, Stein AB, Urbanek K, et al., Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005; 102: 3766-3771.
14. Li Q, Guo Y, Ou Q, et al., Intracoronary administration of cardiac stem cells in mice: A new, improved technique for cell therapy in murine models. Basic Res Cardiol 2011; 106: 849-864.
15. Williams AR, Hatzistergos KE, Addicott B, et al., Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013; 127: 213-223.
16. Welt FG, Gallegos R, Connell J, et al., Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail 2013; 6: 99-106.
17. Takamiya M, Haider KH, Ashraf M,. Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS One 2011; 6: e25265.
18. Bolli R, Chugh AR, D'Amario D, et al., Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-1857.
19. Agoston I, Cameron CS, Yao D, et al., Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol 2004; 94: 1003-1007.
20. Rathore SS, Foody JM, Wang Y, et al., Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 2003; 289: 2517-2524.
21. Singh H, Gordon HS, Deswal A,. Variation by race in factors contributing to heart failure hospitalizations. J Card Fail 2005; 11: 23-29.
22. von Haehling S, Doehner W, Anker SD,. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007; 73: 298-309.
23. Anker SD, Chua TP, Ponikowski P, et al., Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96: 526-534.
24. Ito K, Suda T,. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 2014; 15: 243-256.
25. Gaspar JA, Doss MX, Hengstler JG, et al., Unique metabolic features of stem cells, cardiomyocytes, and their progenitors. Circ Res 2014; 114: 1346-1360.
26. Rota M, LeCapitaine N, Hosoda T, et al., Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 2006; 99: 42-52.
27. Molgat AS, Tilokee EL, Rafatian G, et al., Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity. Circulation 2014; 130: S70-76.
28. Zafir A, Readnower R, Long BW, et al., Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells 2013; 31: 765-775.
29. He JQ, Vu DM, Hunt G, et al., Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One 2011; 6: e27719.
30. Fransioli J, Bailey B, Gude NA, et al., Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 2008; 26: 1315-1324.
31. Mohsin S, Khan M, Toko H, et al., Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 2012; 60: 1278-1287.
32. Perez J, Hill BG, Benavides GA, et al., Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochem J 2010; 428: 255-267.
33. Hill BG, Dranka BP, Zou L, et al., Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J 2009; 424: 99-107.
34. Dranka BP, Hill BG, Darley-Usmar VM,. Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 2010; 48: 905-914.
35. Dranka BP, Benavides GA, Diers AR, et al., Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med 2011; 51: 1621-1635.
36. Sansbury BE, DeMartino AM, Xie Z, et al., Metabolomic analysis of pressure-overloaded and infarcted mouse hearts. Circ Heart Fail 2014; 7: 634-642.
37. Ashcroft SJ, Weerasinghe LC, Bassett JM, et al., The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 1972; 126: 525-532.
38. Elstrom RL, Bauer DE, Buzzai M, et al., Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004; 64: 3892-3899.
39. Vander Heiden MG, Plas DR, Rathmell JC, et al., Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001; 21: 5899-5912.
40. Kato M, Sakai K, Endo A,. Koningic acid (heptelidic acid) inhibition of glyceraldehyde-3-phosphate dehydrogenases from various sources. Biochim Biophys Acta 1992; 1120: 113-116.
41. Sansbury BE, Riggs DW, Brainard RE, et al., Responses of hypertrophied myocytes to reactive species: Implications for glycolysis and electrophile metabolism. Biochem J 2011; 435: 519-528.
42. Bailey B, Izarra A, Alvarez R, et al., Cardiac stem cell genetic engineering using the alphaMHC promoter. Regen Med 2009; 4: 823-833.
43. Hill BG, Benavides GA, Lancaster JR, Jr,. et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 2012; 393: 1485-1512.
44. Phillips M, Enan E, Liu PC, et al., Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci 1995; 108: 395-402.
45. Li R, Blanchette-Mackie EJ, Ladisch S,. Induction of endocytic vesicles by exogenous C(6)-ceramide. J Biol Chem 1999; 274: 21121-21127.
46. Crabtree HG,. Observations on the carbohydrate metabolism of tumours. Biochem J 1929; 23: 536-545.
47. Diaz-Ruiz R, Rigoulet M, Devin A,. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta 2011; 1807: 568-576.
48. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al., The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
49. Duran RV, Oppliger W, Robitaille AM, et al., Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 2012; 47: 349-358.
50. Tang XL, Rokosh G, Sanganalmath SK, et al., Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010; 121: 293-305.
51. Hong KU, Li QH, Guo Y, et al., A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol 2013; 108: 346.
52. Hong KU, Bolli R,. Cardiac stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 2014; 16: 324.
53. Montel-Hagen A, Blanc L, Boyer-Clavel M, et al., The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood 2008; 112: 4729-4738.
54. Tonack S, Rolletschek A, Wobus AM, et al., Differential expression of glucose transporter isoforms during embryonic stem cell differentiation. Differentiation 2006; 74: 499-509.
55. Oburoglu L, Tardito S, Fritz V, et al., Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification. Cell Stem Cell 2014; 15: 169-184.
56. Wang Y, Huang Y, Zhao L, et al., Glutaminase 1 Is Essential for the Differentiation, Proliferation, and Survival of Human Neural Progenitor Cells. Stem Cells Dev 2014.
57. Vega-Naredo I, Loureiro R, Mesquita KA, et al., Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells. Cell Death Differ 2014; 21: 1560-1574.
58. Amores-Sanchez MI, Medina MA,. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metabol 1999; 67: 100-105.
59. Ide T, Tsutsui H, Kinugawa S, et al., Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000; 86: 152-157.
60. Giordano FJ,. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
61. Voet D, Voet JG,. Biochemistry. New York: Wiley; 1995:xvii, 1361 p.
62. Gingras AC, Raught B, Sonenberg N,. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15: 807-826.
63. Gao N, Flynn DC, Zhang Z, et al., G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 2004; 287: C281-291.
64. Wise DR, DeBerardinis RJ, Mancuso A, et al., Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A 2008; 105: 18782-18787.
65. Askanazi J, Elwyn DH, Kinney JM, et al., Muscle and plasma amino acids after injury: The role of inactivity. Ann Surg 1978; 188: 797-803.
66. Smith RJ, Wilmore DW,. Glutamine nutrition and requirements. JPEN J Parenter Enteral Nutr 1990; 14: 94S-99S.
67. Rogeri PS, Costa Rosa LF,. Plasma glutamine concentration in spinal cord injured patients. Life Sci 2005; 77: 2351-2360.
68. Umpleby AM, Carroll PV, Russell-Jones DL, et al., Glutamine supplementation and GH/IGF-I treatment in critically ill patients: Effects on glutamine metabolism and protein balance. Nutrition 2002; 18: 127-129.
69. Askanazi J, Carpentier YA, Michelsen CB, et al., Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg 1980; 192: 78-85.
70. Gottschalk A, Wempe C, Goeters C,. Glutamine in the ICU: Who needs supply? Clin Nutr 2013; 32: 668-669.
71. Khogali SE, Pringle SD, Weryk BV, et al., Is glutamine beneficial in ischemic heart disease? Nutrition 2002; 18: 123-126.
72. He W, Miao FJ, Lin DC, et al., Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004; 429: 188-193.
73. Luttrell DK, Luttrell LM,. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 2004; 23: 7969-7978.